Literature DB >> 25083419

Sentinel lymph node micrometastases and isolated tumor cells in breast cancer: an evolving field.

Fang Fan1.   

Abstract

Entities:  

Year:  2012        PMID： 25083419      PMCID： PMC4115710          DOI： 10.3978/j.issn.2227-684X.2012.04.04

Source DB:  PubMed          Journal:  Gland Surg        ISSN： 2227-684X


× No keyword cloud information.
  8 in total

Review 1.  Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19-22, 2001, Philadelphia, Pennsylvania.

Authors:  Gordon F Schwartz; Armando E Giuliano; Umberto Veronesi
Journal:  Cancer       Date:  2002-05-15       Impact factor: 6.860

2.  American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer.

Authors:  Gary H Lyman; Armando E Giuliano; Mark R Somerfield; Al B Benson; Diane C Bodurka; Harold J Burstein; Alistair J Cochran; Hiram S Cody; Stephen B Edge; Sharon Galper; James A Hayman; Theodore Y Kim; Cheryl L Perkins; Donald A Podoloff; Visa Haran Sivasubramaniam; Roderick R Turner; Richard Wahl; Donald L Weaver; Antonio C Wolff; Eric P Winer
Journal:  J Clin Oncol       Date:  2005-09-12       Impact factor: 44.544

3.  Additional axillary metastases and stage migration in breast cancer patients with micrometastases or submicrometastases in sentinel lymph nodes.

Authors:  Maartje C van Rijk; Johannes L Peterse; Omgo E Nieweg; Hester S A Oldenburg; Emiel J Th Rutgers; Bin B R Kroon
Journal:  Cancer       Date:  2006-08-01       Impact factor: 6.860

4.  The role of axillary lymph node dissection in breast cancer patients with sentinel lymph node micrometastases.

Authors:  M Gipponi; G Canavese; R Lionetto; A Catturich; C Vecchio; A Sapino; D Friedman; F Cafiero
Journal:  Eur J Surg Oncol       Date:  2005-11-21       Impact factor: 4.424

5.  Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial.

Authors:  Armando E Giuliano; Linda McCall; Peter Beitsch; Pat W Whitworth; Peter Blumencranz; A Marilyn Leitch; Sukamal Saha; Kelly K Hunt; Monica Morrow; Karla Ballman
Journal:  Ann Surg       Date:  2010-09       Impact factor: 12.969

6.  Nonsentinel node metastases in breast cancer patients with isolated tumor cells in the sentinel node: implications for completion axillary node dissection.

Authors:  Kristine E Calhoun; Nora M Hansen; Roderick R Turner; Armando E Giuliano
Journal:  Am J Surg       Date:  2005-10       Impact factor: 2.565

Review 7.  The clinical significance of sentinel lymph node micrometastasis in breast cancer.

Authors:  Neill Patani; Kefah Mokbel
Journal:  Breast Cancer Res Treat       Date:  2008-04-20       Impact factor: 4.872

8.  Micrometastases or isolated tumor cells and the outcome of breast cancer.

Authors:  Maaike de Boer; Carolien H M van Deurzen; Jos A A M van Dijck; George F Borm; Paul J van Diest; Eddy M M Adang; Johan W R Nortier; Emiel J T Rutgers; Caroline Seynaeve; Marian B E Menke-Pluymers; Peter Bult; Vivianne C G Tjan-Heijnen
Journal:  N Engl J Med       Date:  2009-08-13       Impact factor: 91.245
  8 in total
  2 in total

1.  A clinical study on regional lymphatic chemotherapy using an activated carbon nanoparticle-epirubicin in patients with breast cancer.

Authors:  Qian Yang; Xiao-dong Wang; Jie Chen; Chun-xiang Tian; Hong-jiang Li; Yu-Juan Chen; Qing Lv
Journal:  Tumour Biol       Date:  2012-09-05

2.  A support vector machine model for predicting non-sentinel lymph node status in patients with sentinel lymph node positive breast cancer.

Authors:  Xiaowen Ding; Shangnao Xie; Jie Chen; Wenju Mo; Hongjian Yang
Journal:  Tumour Biol       Date:  2013-02-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.